Value of routine 'day 14' marrow exam in newly diagnosed AML

T Yezefski¹, H Xie², R Walter³, J Pagel⁴, P S Becker³, P Hendrie⁵, V Sandhu², K Shannon-Dorcy², J Abkowitz⁵, F R Appelbaum⁴, E Estey³

Affiliations

¹ University of Washington School of Medicine, Seattle, WA, USA.
² Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
³ 1] Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA [2] Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA [3] Division of Hematology, Department of Medicine, University of Washington, Seattle, WA, USA.
⁴ 1] Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA [2] Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA.
⁵ Division of Hematology, Department of Medicine, University of Washington, Seattle, WA, USA.

PMID: 25204570
DOI: 10.1038/leu.2014.268

Value of routine 'day 14' marrow exam in newly diagnosed AML

T Yezefski et al. Leukemia. 2015 Jan.

. 2015 Jan;29(1):247-9.

doi: 10.1038/leu.2014.268. Epub 2014 Sep 10.

Authors

T Yezefski¹, H Xie², R Walter³, J Pagel⁴, P S Becker³, P Hendrie⁵, V Sandhu², K Shannon-Dorcy², J Abkowitz⁵, F R Appelbaum⁴, E Estey³

Affiliations

¹ University of Washington School of Medicine, Seattle, WA, USA.
² Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
³ 1] Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA [2] Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA [3] Division of Hematology, Department of Medicine, University of Washington, Seattle, WA, USA.
⁴ 1] Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA [2] Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA.
⁵ Division of Hematology, Department of Medicine, University of Washington, Seattle, WA, USA.

PMID: 25204570
DOI: 10.1038/leu.2014.268

No abstract available

PubMed Disclaimer

Cited by

Literature review and expert opinion on the treatment of high-risk acute myeloid leukemia in patients who are eligible for intensive chemotherapy.
Palmieri R, Billio A, Ferrara F, Galimberti S, Lemoli RM, Todisco E, Moretti F, Venditti A. Palmieri R, et al. Front Oncol. 2024 Feb 20;14:1367393. doi: 10.3389/fonc.2024.1367393. eCollection 2024. Front Oncol. 2024. PMID: 38444680 Free PMC article. Review.
Bone marrow evaluation for diagnosis and monitoring of acute myeloid leukemia.
Percival ME, Lai C, Estey E, Hourigan CS. Percival ME, et al. Blood Rev. 2017 Jul;31(4):185-192. doi: 10.1016/j.blre.2017.01.003. Epub 2017 Feb 2. Blood Rev. 2017. PMID: 28190619 Free PMC article. Review.
The FLAM regimen: revisiting time sequential induction therapy for patients with poor-risk acute myeloid leukemia.
Knapper S. Knapper S. Haematologica. 2015 Sep;100(9):1105-7. doi: 10.3324/haematol.2015.134023. Haematologica. 2015. PMID: 26341523 Free PMC article. No abstract available.
Molecular Measurable Residual Disease Testing of Blood During AML Cytotoxic Therapy for Early Prediction of Clinical Response.
Wong HY, Sung AD, Lindblad KE, Sheela S, Roloff GW, Rizzieri D, Goswami M, Mulé MP, Ramos NR, Tang J, Thompson J, DeStefano CB, Romero K, Dillon LW, Kim DY, Lai C, Hourigan CS. Wong HY, et al. Front Oncol. 2019 Jan 15;8:669. doi: 10.3389/fonc.2018.00669. eCollection 2018. Front Oncol. 2019. PMID: 30697529 Free PMC article.
Revisiting the Role of Day 14 Bone Marrow Biopsy in Acute Myeloid Leukemia.
Jamy O, Bourne G, Mudd TW, Thigpen H, Bhatia R. Jamy O, et al. Cancers (Basel). 2025 Mar 6;17(5):900. doi: 10.3390/cancers17050900. Cancers (Basel). 2025. PMID: 40075747 Free PMC article. Review.

See all "Cited by" articles

References

1. Leukemia. 2014 Mar;28(3):713-6 - PubMed
1. Curr Opin Hematol. 2013 Mar;20(2):93-9 - PubMed
1. Leuk Res. 2013 Jan;37(1):28-31 - PubMed
1. Blood. 2000 Dec 15;96(13):4075-83 - PubMed
1. Am J Hematol. 2008 Jun;83(6):446-50 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Value of routine 'day 14' marrow exam in newly diagnosed AML

Affiliations

Value of routine 'day 14' marrow exam in newly diagnosed AML

Authors

Affiliations

Similar articles

Cited by

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical